Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

<p>Supplemental Figure S1. Mean pharmacokinetic profiles for single agent talazoparib (BMN673 in phase I clinical trial PRP-001) versus combination therapy.</p>

保存先:

書誌詳細
第一著者:	Zev A. Wainberg (15047031) (author)
その他の著者:	Arun S. Singh (15036660) (author), Gottfried E. Konecny (15047034) (author), Kelly E. McCann (15047037) (author), J. Randolph Hecht (15047040) (author), Jonathan Goldman (15047043) (author), Bartosz Chmielowski (15036666) (author), Richard S. Finn (10431048) (author), Neil O'Brien (15047046) (author), Erika Von Euw (15047049) (author), Megan M. Price (15047052) (author), Diego Martinez (15047055) (author), Lisa Yonemoto (15047058) (author), Meghan Brennan (15047061) (author), John A. Glaspy (15047064) (author), Dennis J. Slamon (15047067) (author)
出版事項:	2025
主題:	Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Clinical Trial Results Phase I clinical trials Drug Targets Oncoprotein & tumor suppressor drug targets Preclinical Models In vitro models of cancer
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Cannot write session to /tmp/vufind_sessions/sess_saag63fq2541rd1u3uncmps9uc